(Q46031680)

18 December 2017

title

Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId. (English)

1 reference

18 December 2017

author name string

Sara A Hurvitz

series ordinal

1

1 reference

18 December 2017

John M Timmerman

series ordinal

2

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

18 December 2017

Expert Opinion on Biological Therapy

published in

1 reference

18 December 2017

volume

5

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

page(s)

841-852

1 reference

18 December 2017

Treatment of non-Hodgkin's lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Current treatment of follicular non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Progress and promise in the treatment of indolent lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

131I-tositumomab therapy as initial treatment for follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Spontaneous regression in non-Hodgkin's lymphoma: clinical and pathogenetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

The monoclonality of human B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Antibody to a molecularly-defined antigen confined to a tumour cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Therapeutic idiotype vaccines for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Adoptive transfer of anti-idiotypic T cells cure mice of disseminated B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Myeloma proteins as tumor-specific transplantation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Dendritic cell vaccines for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Baculovirus vectors for expression in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Insect cells as hosts for the expression of recombinant glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

B cells inhibit induction of T cell-dependent tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Rapid expression of vaccine proteins for B-cell lymphoma in a cell-free system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.6.841

21 January 2018

Identifiers

DOI

10.1517/14712598.5.6.841

1 reference

18 December 2017

1 reference

18 December 2017